year 14, Issue 1 (January - February 2020)                   Iran J Med Microbiol 2020, 14(1): 101-115 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Morovati H, Seyyedtabaei S J, Gholamzad M. Evaluation of a Newly Designed Immunochromatographic Test using Gold Nanoparticles and Recombinant Antigen gra7 for Rapid Diagnosis of Human Toxoplasmosis. Iran J Med Microbiol 2020; 14 (1) :101-115
1- Department of Quality Control, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran
2- Department of Parasitology and Mycology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3- Department of Microbiology and Immunology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, IRAN ,
Abstract:   (4628 Views)
Background:  One of the most important complications of toxoplasmosis is its early diagnosis. It seems that GRA7 protein can be a good candidate for detection of the acute phase in Toxoplasmosis. Accordingly, the present study aimed to diagnose toxoplasmosis via a newly immunochromatographic test using recombinant antigen gra7.
Methods:  The parasite was cultured in mice and then were used for DNA extraction. The gra7 gene was amplified by PCR and cloned into the pET-32a (+) plasmid. Thereafter, the recombinant vector was transferred into the Escherichia coli Rosetta strain and gra7 was detected via SDS-PAGE and western blotting. The bacterial lysate was used to purify the protein by Ni-NTA affinity chromatography .Anti-human gold conjugated antibody, test line and control line were injected to conjugate pad and nitrocellulose membrane, respectively, and all the layer were assembled. By using serum of patients and healthy individuals, manufactured kits were evaluated.
Results:  Our results indicated that the selected gene was correctly cloned and the protein of interest was produced and purified. The test revealed sensitivity and specificity of 100 and 96.7 percent, respectively. The kit was also shown to be stable over 16 weeks in 37°C.
Conclusion:  The choice of antigen based on cellular and clinical features of the parasite, as well as the use of previous outcomes yielded to develop a rapid diagnostic test for toxoplasmosis.
Full-Text [PDF 1543 kb]   (1604 Downloads) |   |   Full-Text (HTML)  (1407 Views)  
Type of Study: Original Research Article | Subject: Medical Parasitology
Received: 2019/11/27 | Accepted: 2019/12/29 | ePublished: 2020/01/1

1. Dubey JP. The history of Toxoplasma gondii-the first 100 years. J Eukaryot Microbiol 2008;55(6):467-75. [DOI:10.1111/j.1550-7408.2008.00345.x] [PMID]
2. Wolf A, Cowen D, Paige B. Human toxoplasmosis: occurrence in infants as an encephalomyelitis verification by transmission to animals. Science (Washington). 1939;89(2306). [DOI:10.1126/science.89.2306.226] [PMID]
3. Mamidi A, DeSimone JA, Pomerantz RJ. Central nervous system infections in individuals with HIV-1 infection. J Neurovirol. 2002;8(3):158-67. [DOI:10.1080/13550280290049723] [PMID]
4. Gross U, Holpert M, Goebel S. Impact of stage differentiation on diagnosis of toxoplasmosis. Ann Ist Super Sanita. 2004;40(1):65-70.
5. Prince HE, Wilson M. Simplified assay for measuring Toxoplasma gondii immunoglobulin G avidity. Clin Diagn Lab Immunol. 2001;8(5):904-8. [DOI:10.1128/CDLI.8.5.904-908.2001] [PMID] [PMCID]
6. Pfrepper K-I, Enders G, Gohl M, Krczal D, Hlobil H, Wassenberg D, et al. Seroreactivity to and avidity for recombinant antigens in toxoplasmosis. Clin Diagn Lab Immunol. 2005;12(8):977-82. [DOI:10.1128/CDLI.12.8.977-982.2005] [PMID] [PMCID]
7. Roberts A, Hedman K, Luyasu V, Zufferey J, Bessières M-H, Blatz R-M, et al. Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Clin Microbiol Infect. 2001;20(7):467-74. [DOI:10.1007/PL00011289] [PMID]
8. Abdizadeh R, Maraghi S, Ghadiri AA, Tavalla M, Shojaee S. Cloning and Expression of Major Surface Antigen 1 Gene of Toxoplasma gondii RH Strain Using the Expression Vector pVAX1 in Chinese Hamster Ovary Cells. Jundishapur J Microbiol. 2015;8(3):e22570. [DOI:10.5812/jjm.22570]
9. Grzybowski MM, Dziadek B, Dziadek J, Gatkowska J, Dzitko K, Dlugonska H. Toxoplasma gondii: cloning, expression and immunoreactivity of recombinant ROP5 and ROP18 antigens. Exp. Parasitol. 2015;150:1-6. [DOI:10.1016/j.exppara.2015.01.006] [PMID]
10. Kotresha D, Noordin R. Recombinant proteins in the diagnosis of toxoplasmosis. Apmis. 2010;118(8):529-42. [DOI:10.1111/j.1600-0463.2010.02629.x] [PMID]
11. Araújo PRB, Ferreira AW. High diagnostic efficiency of IgM-ELISA with the use of multiple antigen peptides (MAP1) from T. gondii ESA (SAG-1, GRA-1 and GRA-7), in acute toxoplasmosis. Rev Inst Med Trop Sao Paulo. 2010;52(2):63-8. [DOI:10.1590/S0036-46652010000200001] [PMID]
12. Dunn JD, Ravindran S, Kim S-K, Boothroyd JC. The Toxoplasma gondii dense granule protein GRA7 is phosphorylated upon invasion and forms an unexpected association with the rhoptry proteins ROP2 and ROP4. Infect Immun. 2008;76(12):5853-61. [DOI:10.1128/IAI.01667-07] [PMID] [PMCID]
13. Igarashi M, Kano F, Tamekuni K, Kawasaki P, Navarro I, Vidotto O, et al. Toxoplasma gondii: cloning, sequencing, expression, and antigenic characterization of ROP2, GRA5 and GRA7. Genet Mol Res. 2008:305-13. [DOI:10.4238/vol7-2gmr423] [PMID]
14. Sun X, Wang Z, Li J, Wei F, Liu Q. Evaluation of an indirect ELISA using recombinant granule antigen GRA1, GRA7 and soluble antigens for serodiagnosis of Toxoplasma gondii infection in chickens. Res Vet Sci. 2015;100:161-4. [DOI:10.1016/j.rvsc.2015.04.011] [PMID]
15. Wang Z, Ge W, Huang S-Y, Li J, Zhu X-Q, Liu Q. Evaluation of recombinant granule antigens GRA1 and GRA7 for serodiagnosis of Toxoplasma gondii infection in dogs. BMC Vet Res. 2014;10(1):158. [DOI:10.1186/1746-6148-10-158] [PMID] [PMCID]
16. Wang Z, Ge W, Li J, Song M, Sun H, Wei F, et al. Production and evaluation of recombinant granule antigen protein GRA7 for serodiagnosis of Toxoplasma gondii infection in cattle. Foodborne Pathog Dis. 2014;11(9):734-9. [DOI:10.1089/fpd.2014.1749] [PMID]
17. Gopal GJ, Kumar A. Strategies for the production of recombinant protein in Escherichia coli. Protein J. 2013;32(6):419-25. [DOI:10.1007/s10930-013-9502-5] [PMID]
18. Wang Y, Wang L, Zhang J, Wang G, Chen W, Chen L, et al. Preparation of colloidal gold immunochromatographic strip for detection of Paragonimiasis skrjabini. PloS one. 2014;9(3):e92034. [DOI:10.1371/journal.pone.0092034] [PMID] [PMCID]
19. Ferreira MS, Borges AS. Some aspects of protozoan infections in immunocompromised patients- a review. Mem Inst Oswaldo Cruz. 2002;97(4):443-57. [DOI:10.1590/S0074-02762002000400001] [PMID]
20. Wallon M, Peyron F. Congenital Toxoplasmosis: A Plea for a Neglected Disease. PLoS Pathog. 2018;7(1):25. [DOI:10.3390/pathogens7010025] [PMID] [PMCID]
21. Beghetto E, Buffolano W, Spadoni A, Del Pezzo M, Di Cristina M, Minenkova O, et al. Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy. Clin Microbiol Rev. 2003;41(12):5414-8. [DOI:10.1128/JCM.41.12.5414-5418.2003] [PMID] [PMCID]
22. Dubey J, Jones J. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol Parasites Wildl. 2008;38(11):1257-78. [DOI:10.1016/j.ijpara.2008.03.007] [PMID]
23. Hiszczyńska-Sawicka Eb, Brillowska-Dąbrowska A, Dąbrowski S, Pietkiewicz H, Myjak P, Kur J. High yield expression and single-step purification of Toxoplasma gondii SAG1, GRA1, and GRA7 antigens in Escherichia coli. Protein Expr Purif. 2003;27(1):150-7. [DOI:10.1016/S1046-5928(02)00593-4]
24. Babaie J, Miri M, Sadeghiani G, Zare M, Khalili G, Golkar M. Expression and Single-step Purification of GRA8 Antigen of Toxoplasma gondii in Escherichia coli. Avicenna J Med Biotechnol. 2011;3(2):67-77.
25. Walls D, Loughran ST. Tagging recombinant proteins to enhance solubility and aid purification. Methods Mol Biol (Clifton, NJ). 2011;681:151-75. [DOI:10.1007/978-1-60761-913-0_9] [PMID]
26. Wong RC, Tse HY. Lateral flow immunoassay. New York: Springer; 2009. [DOI:10.1007/978-1-59745-240-3]
27. Wang Y-H, Li X-R, Wang G-X, Yin H, Cai X-P, Fu B-Q, et al. Development of an immunochromatographic strip for the rapid detection of Toxoplasma gondii circulating antigens. Parasitol Int. 2011;60(1):105-7. [DOI:10.1016/j.parint.2010.11.002] [PMID]
28. Yan H, Yan H, Tao Y, Chen H, Li G, Gong W, et al. Application and expression of Toxoplasma gondii surface antigen 2 (SAG2) and rhoptry protein 2 (ROP2) from recombinant Escherichia coli strain. Trans R Soc Trop Med Hyg. 2012;106(6):356-62. [DOI:10.1016/j.trstmh.2012.02.008] [PMID]
29. Chapey E, Wallon M, Peyron F. Evaluation of the LDBIO point of care test for the combined detection of toxoplasmic IgG and IgM. Clin Chim Acta. 2017;464:200-1. [DOI:10.1016/j.cca.2016.10.023] [PMID]
30. Mahinc C, Flori P, Delaunay E, Guillerme C, Charaoui S, Raberin H, et al. Evaluation of a new ICT test (LDBIO Diagnostics) to detect toxoplasma IgG and IgM: comparison with the routine Architect technique. J Clin Microbiol. 2017:JCM. 01106-17. [DOI:10.1128/JCM.01106-17] [PMID] [PMCID]
31. Kim YH, hoo Lee J, kyu Ahn S, Kim T-S, Hong S-J, Chong C-K, et al. Seroprevalence of Toxoplasmosis with ELISA and Rapid Diagnostic Test among Residents in Gyodong-do, Inchon city, Korea: A Four-Year Follow-up. Korean J Parasitol. 2017;55(3):247. [DOI:10.3347/kjp.2017.55.3.247] [PMID] [PMCID]
32. Teimouri A, Modarressi MH, Shojaee S, Mohebali M, Rezaian M, Keshavarz H. Development, optimization, and validation of an in-house Dot-ELISA rapid test based on SAG1 and GRA7 proteins for serological detection of Toxoplasma gondii infections. J Glob Antimicrob Resist. 2019; 12:2657. [DOI:10.2147/IDR.S219281] [PMID] [PMCID]
33. YBAÑEZ RH, KYAN H, NISHIKAWA Y. Detection of antibodies against Toxoplasma gondii in cats using an immunochromatographic test based on GRA7 antigen. J Vet Med Sci. 2020:19-0654. [DOI:10.1292/jvms.19-0654] [PMID]
34. Begeman IJ, Lykins J, Zhou Y, Lai BS, Levigne P, El Bissati K, et al. Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries. PLoS Negl Trop Dis. 2017;11(6):e0005670. [DOI:10.1371/journal.pntd.0005670] [PMID] [PMCID]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc